NuVasive

NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

Earnings data Q2 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NuVasive is a medical device company that creates minimally invasive surgical products and procedurally integrated spine solutions. Its minimally invasive, procedurally integrated surgical solutions are intended to produce repeatable and clinically proven results.

SAN DIEGO, Nov. 18, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive CEO J. Christopher Barry will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

NuVasive to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference

Globus Medical

NuVasive's (NUVA) declining spine implant business might get a boost if its consolidation with Globus Medical takes place.

NuVasive (NUVA) Up on Rumors of Takeover by Globus Medical

NuVasive (NUVA) reported lower-than-expected earnings and revenues with COVID-led headwinds and healthcare staffing shortages dampening the Q3 top-line growth.

NuVasive (NUVA) Q3 Earnings Miss Estimates, 2021 Guidance Down

NuVasive Inc (NASDAQ: NUVA) reported Q3 net sales of $270.8 million, an 8.3% decrease on a reported and constant currency basis, missing the consensus of $291.79 million. "The third quarter presented unexpected challenges for elective surgical procedures due to the negative impact from the resurgence of COVID-19 and healthcare staffing shortages," said J.

NuVasive's Q3 Earnings Hit By COVID-19, Staff Shortage; Cuts FY21 Guidance

NuVasive, Inc. (NUVA) CEO Christopher Barry on Q3 2021 Results - Earnings Call Transcript

NuVasive (NUVA) delivered earnings and revenue surprises of -40.74% and -7.03%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

NuVasive (NUVA) Misses Q3 Earnings and Revenue Estimates

NuVasive (NASDAQ:NUVA) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

NuVasive: Q3 Earnings Insights

SAN DIEGO, Nov. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended September 30, 2021. Third Quarter 2021 Net sales decreased 8.3% to $270.8 million, on a reported and constant currency basis, compared to the prior year period; GAAP operating margin of (2.4%); Non-GAAP operating margin of 11.2%; and GAAP diluted loss per share of $0.42; Non-GAAP diluted earnings per share of $0.32.

NuVasive Announces Third Quarter 2021 Financial Results

NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NuVasive (NUVA) Reports Next Week: What Awaits?

SAN DIEGO, Nov. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will virtually present at the Credit Suisse 30th Annual Healthcare Conference on Thursday, November 11, 2021 at 8:20 a.m. PT / 11:20 a.m.

NuVasive to Present at Credit Suisse 30th Annual Healthcare Conference

SAN DIEGO, Oct. 28, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will sponsor and participate in the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum '21 in Las Vegas from October 28 to 30, 2021. "We continue to invest in and support clinically focused organizations like SMISS for their dedication to research and education to advance less invasive spine surgery," said Massimo Calafiore, chief commercial officer at NuVasive.

NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Annual Forum '21

SAN DIEGO, Oct. 27 , 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the upcoming release of a cutting-edge virtual reality (VR) training module for the NuVasive X360® system to complement its market-leading Clinical Professional Development (CPD) program. In collaboration with PrecisionOS®, developers of a medical-grade VR™ learning platform, the NuVasive X360 VR training module integrates the Company's comprehensive lateral approach to single-position spine surgery, which includes XLIF®, XALIF™, and XFixation™, into a virtual simulation of the procedural workflow.

NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery

SAN DIEGO, Oct. 25, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter 2021 earnings results on Tuesday, November 9, 2021, after the close of the market. NuVasive will hold a conference call on Tuesday, November 9, 2021, at 4:30 p.m.

NuVasive Announces Conference Call and Webcast of Third Quarter 2021 Results

According to NuVasive (NUVA), Porous PEEK is a clear differentiator for the company in the market.

NuVasive (NUVA) Announces Two Developments in Cohere TLIF Line

SAN DIEGO, Oct. 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of the Cohere® TLIF-O implant and upcoming launch of the Cohere TLIF-A implant planned for later in the fourth quarter. With these additions to its Advanced Materials Science™ (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery.1 "NuVasive is focused on providing a comprehensive spine offering across all procedural segments to address some of the most challenging aspects of spine surgery.

NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery

SAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced Drs.

NuVasive Announces First Commercial Cases Utilizing the Pulse Platform

NuVasive's (NUVA) East Coast Experience Center reflects the company's commitment to provide best quality surgeon education and training to enhance the standard of patient care in spine surgery.

NuVasive (NUVA) Expands Training Opportunities With New Center

SAN DIEGO, Sept. 23, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the opening of its East Coast Experience Center in the New York metropolitan area, expanding opportunities to train more surgeons and change more patient lives.

NuVasive Opens East Coast Experience Center in New York Metropolitan Area

SAN DIEGO, Sept. 22, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its long-standing partnership with the Scoliosis Research Society (SRS) with a double diamond sponsorship and will attend the society's 56th Annual Meeting from September 22 to 25, 2021 in St. Louis, Mo.

NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship

SAN DIEGO, Sept. 9, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the NuVasive Simplify® Cervical Disc one-level U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study data was recently published in the International Journal of Spine Surgery.

NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

NuVasive (NUVA) is a Top-Ranked Growth Stock: Should You Buy?

SAN DIEGO , Sept. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced new executive leadership roles, strengthening its innovation and go-to-market teams while furthering the Company's growth.

NuVasive Announces New Executive Leadership Roles

SAN DIEGO, Aug. 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will virtually present at the Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 9:30 a.m. PT / 12:30 p.m.

NuVasive to Present at Upcoming Investor Conference

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock?

NuVasive (NUVA) Down 6.1% Since Last Earnings Report: Can It Rebound?

NuVasive's XLIF procedure and Pulse platform will drive its long-term revenue growth. In addition, the company's surgical access instruments will drive revenue growth as well.

News for NuVasive Stock (NUVA)